SARILUMAB

SARILUMAB was reported 27761 times

SARILUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 1265 0.3963
1 LUPUS VULGARIS 474 0.3762
2 VERTEBRAL LATERAL RECESS STENOSIS 7 0.3684
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2619 0.3652
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 237 0.3548
5 SWOLLEN JOINT COUNT 87 0.3480
6 RHEUMATIC FEVER 1540 0.3451
7 RHEUMATOID FACTOR POSITIVE 1972 0.3411
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 681 0.3400
9 GRIP STRENGTH 77 0.3362
10 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 187 0.3333
11 C-REACTIVE PROTEIN 308 0.3323
12 DUODENAL ULCER PERFORATION 2210 0.2969
13 FACET JOINT SYNDROME 906 0.2780
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 561 0.2705
15 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 6 0.2609
16 MYELODYSPLASTIC SYNDROME UNCLASSIFIABLE 9 0.2571
17 DISLOCATION OF VERTEBRA 576 0.2523
18 X-RAY ABNORMAL 434 0.2425
19 HEPATIC ENZYME 35 0.2349
20 PEMPHIGUS 2855 0.2281
21 RETINITIS 382 0.2209
22 HAND DEFORMITY 2791 0.2126
23 HELICOBACTER INFECTION 2104 0.2045
24 PERIPHERAL VENOUS DISEASE 707 0.1729
25 HYPOCHOLESTEROLAEMIA 59 0.1671
26 MUSCLE INJURY 1368 0.1649
27 PERICARDITIS 2731 0.1624
28 TENDER JOINT COUNT 13 0.1548
29 OVERLAP SYNDROME 108 0.1543
30 LIGAMENTUM FLAVUM HYPERTROPHY 7 0.1522
31 SYNOVITIS 2707 0.1500
32 FOLLICULITIS 1485 0.1415
33 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 874 0.1344
34 NONALCOHOLIC FATTY LIVER DISEASE 26 0.1327
35 SERONEGATIVE ARTHRITIS 149 0.1300
36 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 13 0.1238
37 GLOSSODYNIA 2756 0.1230
38 BREAST CANCER STAGE III 790 0.1219
39 C-REACTIVE PROTEIN ABNORMAL 763 0.1188
40 BONE EROSION 413 0.1167
41 PORPHYRIA ACUTE 143 0.0997
42 ACQUIRED PORPHYRIA 7 0.0986
43 OSTEOARTHROPATHY 7 0.0959
44 ONYCHOMADESIS 401 0.0955
45 WOUND 2657 0.0950
46 LIVE BIRTH 786 0.0939
47 DRUG TOLERANCE DECREASED 262 0.0932
48 HYPERCHOLESTEROLAEMIA 900 0.0931
49 GRIP STRENGTH DECREASED 820 0.0931
50 LIP DRY 836 0.0919
51 ACTIVITIES OF DAILY LIVING DECREASED 53 0.0828
52 BLEPHAROSPASM 519 0.0823
53 SYSTEMIC LUPUS ERYTHEMATOSUS 2917 0.0821
54 PURULENT PERICARDITIS 9 0.0804
55 BURSITIS 957 0.0788
56 WOUND INFECTION 833 0.0760
57 JOINT RANGE OF MOTION DECREASED 969 0.0722
58 POLYMYALGIA RHEUMATICA 228 0.0717
59 AUTOIMMUNE DISORDER 689 0.0706
60 CONTRAINDICATED PRODUCT ADMINISTERED 2057 0.0679
61 IRRITABLE BOWEL SYNDROME 1431 0.0667
62 ONYCHOMYCOSIS 280 0.0638
63 NEUTROPHIL COUNT 13 0.0619
64 FIBROMYALGIA 1497 0.0615
65 LIVER INJURY 1483 0.0604
66 DEATH NEONATAL 84 0.0603
67 HIP ARTHROPLASTY 886 0.0578
68 NAIL DISORDER 482 0.0550
69 PUSTULAR PSORIASIS 187 0.0544
70 INFUSION SITE REACTION 158 0.0528
71 FINGER DEFORMITY 254 0.0524
72 TYPE 2 DIABETES MELLITUS 1739 0.0516
73 WALKING AID USER 339 0.0514
74 EXOSTOSIS 459 0.0502
75 KERATITIS BACTERIAL 8 0.0491
76 ARTHROPATHY 2700 0.0485
77 BREAST CANCER STAGE II 373 0.0448
78 IMPAIRED HEALING 1447 0.0440
79 HEPATIC ENZYME INCREASED 2991 0.0438
80 ULCER HAEMORRHAGE 293 0.0433
81 OBESITY 685 0.0430
82 KNEE ARTHROPLASTY 895 0.0425
83 MATERNAL EXPOSURE TIMING UNSPECIFIED 159 0.0423
84 RHEUMATOID ARTHRITIS 4773 0.0420
85 LUPUS-LIKE SYNDROME 377 0.0415
86 INFUSION RELATED REACTION 2680 0.0404
87 BLOOD CHOLESTEROL INCREASED 1864 0.0399
88 JOINT SWELLING 4778 0.0395
89 RASH VESICULAR 191 0.0395
90 DISCOMFORT 2408 0.0394
91 PSORIATIC ARTHROPATHY 1578 0.0388
92 EYE INJURY 118 0.0388
93 SCIATICA 616 0.0386
94 PULMONARY FIBROSIS 741 0.0386
95 PRODUCT LABEL CONFUSION 223 0.0382
96 BACK INJURY 413 0.0379
97 PRESCRIBED OVERDOSE 723 0.0373
98 UPPER RESPIRATORY TRACT INFECTION BACTERIAL 8 0.0372
99 THERAPEUTIC PRODUCT EFFECT DECREASED 1666 0.0372
100 RED BLOOD CELL SEDIMENTATION RATE INCREASED 407 0.0367
101 EYE ULCER 21 0.0365
102 LOWER LIMB FRACTURE 674 0.0350
103 BLISTER 1949 0.0347
104 INJECTION SITE EXFOLIATION 23 0.0345
105 INJECTION SITE DRYNESS 31 0.0343
106 GAIT INABILITY 1138 0.0340
107 MYCOBACTERIUM CHELONAE INFECTION 25 0.0338
108 FOOT DEFORMITY 368 0.0332
109 LOWER RESPIRATORY TRACT INFECTION 1494 0.0328
110 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 10 0.0318
111 ANTIPHOSPHOLIPID ANTIBODIES 6 0.0308
112 SWELLING 2768 0.0295
113 JOINT DISLOCATION 312 0.0295
114 SPONDYLITIS 102 0.0280
115 JOINT DESTRUCTION 43 0.0276
116 PERFORATION 22 0.0273
117 DRUG INTOLERANCE 2604 0.0269
118 JOINT SPACE NARROWING 8 0.0268
119 NON-ALCOHOLIC FATTY LIVER 9 0.0267
120 STOMATITIS 1601 0.0264
121 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1265 0.0263
122 COELIAC DISEASE 258 0.0263
123 OSTEOARTHRITIS 1095 0.0258
124 MATERNAL EXPOSURE DURING PREGNANCY 2275 0.0255
125 MOBILITY DECREASED 1830 0.0254
126 HEPATIC CIRRHOSIS 476 0.0253
127 TREATMENT FAILURE 2077 0.0250
128 NIGHT SWEATS 805 0.0250
129 NAIL OPERATION 10 0.0242
130 C-REACTIVE PROTEIN INCREASED 846 0.0232
131 PRESCRIBED UNDERDOSE 463 0.0232
132 MYOSITIS 207 0.0230
133 MUSCULOSKELETAL STIFFNESS 1994 0.0227
134 NORMAL NEWBORN 122 0.0224
135 INJURY 1573 0.0224
136 GENERAL SYMPTOM 161 0.0215
137 INFLAMMATION 1107 0.0214
138 LIVER FUNCTION TEST INCREASED 455 0.0212
139 SPINAL FUSION SURGERY 84 0.0207
140 TASTE DISORDER 418 0.0206
141 DRUG TOLERANCE 103 0.0203
142 JOINT STIFFNESS 526 0.0200
143 EPILEPSY 605 0.0198
144 WHEEZING 1162 0.0196
145 POLYCHONDRITIS 8 0.0190
146 ILL-DEFINED DISORDER 1135 0.0187
147 OEDEMA 1000 0.0184
148 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 315 0.0184
149 ABDOMINAL DISCOMFORT 3072 0.0183
150 GENERAL PHYSICAL HEALTH DETERIORATION 2087 0.0180
151 MUCOSAL ULCERATION 18 0.0178
152 DISABILITY 344 0.0174
153 DELIRIUM 597 0.0172
154 INJECTION SITE RASH 523 0.0170
155 LUNG DISORDER 820 0.0167
156 CONGENITAL ANOMALY 128 0.0165
157 EAR INFECTION 428 0.0161
158 ALOPECIA 3134 0.0159
159 SLEEP DISORDER 1099 0.0156
160 MUSCULOSKELETAL PAIN 797 0.0152
161 THERAPY NON-RESPONDER 673 0.0150
162 GASTROINTESTINAL DISORDER 1329 0.0148
163 ROAD TRAFFIC ACCIDENT 618 0.0148
164 EXPOSURE DURING PREGNANCY 917 0.0147
165 PREGNANCY 291 0.0145
166 HYPERSENSITIVITY 2691 0.0145
167 EAR PAIN 280 0.0144
168 INTENTIONAL PRODUCT USE ISSUE 1250 0.0143
169 DRUG-INDUCED LIVER INJURY 447 0.0142
170 CONTUSION 1280 0.0133
171 ARTHRALGIA 5500 0.0132
172 INJECTION SITE PRURITUS 886 0.0132
173 POLYARTHRITIS 69 0.0131
174 ADVERSE REACTION 173 0.0130
175 LIVER DISORDER 577 0.0130
176 BACK DISORDER 210 0.0129
177 CONDITION AGGRAVATED 3892 0.0128
178 DRY MOUTH 1036 0.0128
179 TOE OPERATION 10 0.0127
180 SINUSITIS 1290 0.0126
181 INJECTION SITE REACTION 860 0.0125
182 RENAL ABSCESS 10 0.0122
183 BONE FISSURE 5 0.0120
184 PERIPHERAL SWELLING 1828 0.0119
185 INFECTION 1653 0.0114
186 HEPATITIS 274 0.0107
187 JOINT ARTHROPLASTY 19 0.0106
188 MYELOPROLIFERATIVE NEOPLASM 7 0.0106
189 BLOOD CHOLESTEROL 5 0.0105
190 BLOODY DISCHARGE 12 0.0105
191 PAIN 6401 0.0104
192 PRODUCT USE ISSUE 1954 0.0104
193 HYPOAESTHESIA 1553 0.0104
194 DYSPEPSIA 1012 0.0103
195 MIGRAINE 980 0.0103
196 NASOPHARYNGITIS 1800 0.0098
197 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 165 0.0097
198 CONFUSIONAL STATE 1564 0.0097
199 JOINT WARMTH 12 0.0096
200 PRODUCT USE IN UNAPPROVED INDICATION 2369 0.0095
201 OSTEOPOROSIS 389 0.0094
202 URTICARIA 1570 0.0094
203 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 625 0.0088
204 APHTHOUS ULCER 68 0.0088
205 RESPIRATORY DISORDER 261 0.0087
206 ORAL DISCOMFORT 121 0.0087
207 THERAPEUTIC RESPONSE DECREASED 526 0.0087
208 INJECTION SITE SWELLING 664 0.0087
209 AMNESIA 552 0.0085
210 INJECTION SITE HYPERSENSITIVITY 26 0.0083
211 ADVERSE EVENT 761 0.0082
212 HYPERTENSION 1749 0.0082
213 NECK PAIN 458 0.0082
214 INJECTION SITE ERYTHEMA 1005 0.0081
215 HYPERTRANSAMINASAEMIA 56 0.0080
216 ADVERSE DRUG REACTION 716 0.0080
217 EXPOSURE TO COMMUNICABLE DISEASE 6 0.0080
218 ARTHRODESIS 8 0.0079
219 RASH 3411 0.0078
220 SPINAL STENOSIS 32 0.0077
221 ENDOCARDITIS BACTERIAL 6 0.0076
222 ABDOMINAL PAIN UPPER 1535 0.0074
223 GAIT DISTURBANCE 1421 0.0074
224 EPISCLERITIS 5 0.0072
225 SCIATIC NERVE INJURY 6 0.0072
226 PRODUCT USED FOR UNKNOWN INDICATION 9 0.0071
227 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19 0.0071
228 ARTHRITIS 540 0.0069
229 PRODUCT DOSE OMISSION IN ERROR 194 0.0068
230 MEMORY IMPAIRMENT 928 0.0067
231 ASTHMA 754 0.0067
232 WEIGHT INCREASED 1487 0.0066
233 INFECTIOUS PLEURAL EFFUSION 10 0.0066
234 GASTROOESOPHAGEAL REFLUX DISEASE 528 0.0066
235 SKIN SWELLING 56 0.0064
236 INJECTION SITE INFLAMMATION 32 0.0064
237 MUSCULAR WEAKNESS 727 0.0064
238 EXTRADURAL ABSCESS 5 0.0064
239 JUVENILE IDIOPATHIC ARTHRITIS 15 0.0061
240 PAIN IN EXTREMITY 1801 0.0061
241 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 14 0.0061
242 INJECTION SITE URTICARIA 149 0.0061
243 INJECTION RELATED REACTION 10 0.0061
244 INJECTION SITE IRRITATION 77 0.0060
245 GIANT CELL ARTERITIS 5 0.0060
246 PNEUMONIA PSEUDOMONAL 9 0.0059
247 COLONIC ABSCESS 5 0.0058
248 INJECTION SITE OEDEMA 10 0.0058
249 RHEUMATOID NODULE 16 0.0058
250 INTERNATIONAL NORMALISED RATIO FLUCTUATION 12 0.0058
251 UPPER RESPIRATORY TRACT INFECTION 267 0.0058
252 INJECTION SITE WARMTH 117 0.0057
253 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 10 0.0057
254 DECREASED APPETITE 1314 0.0057
255 INJECTION SITE VESICLES 34 0.0056
256 SINUS PAIN 13 0.0056
257 POST HERPETIC NEURALGIA 8 0.0056
258 CHEST PAIN 1018 0.0055
259 AORTIC DILATATION 6 0.0054
260 LYME DISEASE 18 0.0054
261 MUSCLE SPASTICITY 66 0.0054
262 FREQUENT BOWEL MOVEMENTS 145 0.0054
263 CEREBRAL TOXOPLASMOSIS 5 0.0054
264 INTERCEPTED PRODUCT STORAGE ERROR 19 0.0053
265 WEIGHT FLUCTUATION 53 0.0051
266 WHITE BLOOD CELL COUNT ABNORMAL 32 0.0050
267 PARAESTHESIA 788 0.0050
268 JOINT INSTABILITY 7 0.0050
269 WHITE BLOOD CELL COUNT DECREASED 528 0.0049
270 DENTAL OPERATION 12 0.0049
271 INFLAMMATORY MARKER INCREASED 24 0.0048
272 DRUG INEFFECTIVE 6342 0.0048
273 INJECTION SITE DISCOLOURATION 60 0.0048
274 MEDICATION ERROR 266 0.0048
275 CARPAL TUNNEL DECOMPRESSION 5 0.0047
276 ANKLE OPERATION 7 0.0047
277 FATIGUE 3672 0.0047
278 LABORATORY TEST ABNORMAL 139 0.0047
279 IMPETIGO 7 0.0047
280 MUSCLE SPASMS 857 0.0047
281 SPINAL OPERATION 57 0.0046
282 DEPRESSION 1047 0.0046
283 ASPARTATE AMINOTRANSFERASE ABNORMAL 7 0.0046
284 PRURITUS 1765 0.0046
285 IMMUNODEFICIENCY 67 0.0045
286 PNEUMONIA 1451 0.0045
287 SKIN WARM 26 0.0045
288 DIVERTICULUM INTESTINAL HAEMORRHAGIC 10 0.0044
289 FOOT OPERATION 22 0.0044
290 ILLNESS 457 0.0044
291 KNEE OPERATION 43 0.0044
292 ADRENAL INSUFFICIENCY 53 0.0044
293 OEDEMA PERIPHERAL 527 0.0043
294 RHINORRHOEA 277 0.0043
295 GLOMERULAR FILTRATION RATE ABNORMAL 6 0.0042
296 SUSPECTED OFF LABEL USE 19 0.0042
297 NOROVIRUS INFECTION 6 0.0042
298 COLITIS ULCERATIVE 184 0.0041
299 EXPOSURE VIA SKIN CONTACT 106 0.0041
300 MALAISE 1785 0.0041
301 WHITE BLOOD CELL COUNT INCREASED 155 0.0040
302 PLATELET DISORDER 10 0.0040
303 DRUG EFFECT LESS THAN EXPECTED 58 0.0039
304 RASH PRURITIC 212 0.0039
305 NECK SURGERY 9 0.0039
306 ABDOMINAL OPERATION 5 0.0038
307 SURGERY 225 0.0038
308 PNEUMONIA BACTERIAL 35 0.0038
309 MOUTH ULCERATION 79 0.0037
310 SHOULDER OPERATION 16 0.0037
311 SHOULDER ARTHROPLASTY 10 0.0037
312 INFECTED SKIN ULCER 7 0.0037
313 FLUID RETENTION 188 0.0037
314 THERAPEUTIC RESPONSE SHORTENED 122 0.0037
315 TRIGGER FINGER 15 0.0037
316 SHOULDER FRACTURE 6 0.0037
317 DIVERTICULITIS 101 0.0036
318 RHINALGIA 10 0.0036
319 LEUKOPENIA 182 0.0036
320 PYREXIA 1258 0.0036
321 SARS-COV-2 TEST POSITIVE 48 0.0036
322 HEPATIC ENZYME ABNORMAL 18 0.0036
323 DISCHARGE 5 0.0036
324 HEADACHE 2259 0.0036
325 JOINT NOISE 7 0.0036
326 TONGUE ULCERATION 12 0.0035
327 LIMB OPERATION 17 0.0035
328 DUODENAL ULCER 25 0.0035
329 INJECTION SITE BRUISING 282 0.0035
330 JOINT LOCK 10 0.0035
331 PHYSICAL DECONDITIONING 9 0.0035
332 COVID-19 PNEUMONIA 41 0.0035
333 LIPIDS INCREASED 7 0.0035
334 ORAL SURGERY 8 0.0034
335 LYMPHOPROLIFERATIVE DISORDER 10 0.0034
336 NECROTISING FASCIITIS 12 0.0034
337 DIVERTICULAR PERFORATION 7 0.0034
338 AORTIC VALVE STENOSIS 6 0.0034
339 WHITE BLOOD CELL DISORDER 9 0.0034
340 INJECTION SITE MASS 124 0.0033
341 NASAL CONGESTION 197 0.0033
342 IMPAIRED QUALITY OF LIFE 48 0.0033
343 JOINT EFFUSION 23 0.0033
344 IRON DEFICIENCY 15 0.0033
345 BRONCHITIS 245 0.0033
346 REBOUND EFFECT 37 0.0033
347 VOMITING 1539 0.0033
348 TOOTH INFECTION 43 0.0033
349 SYNOVIAL CYST 15 0.0032
350 VISUAL IMPAIRMENT 401 0.0032
351 LYMPH NODE PAIN 6 0.0032
352 ABDOMINAL DISTENSION 334 0.0032
353 MUSCULOSKELETAL DISCOMFORT 55 0.0032
354 IMMUNE SYSTEM DISORDER 42 0.0032
355 INTERVERTEBRAL DISCITIS 6 0.0032
356 INSOMNIA 845 0.0032
357 INJECTION SITE SCAR 9 0.0032
358 ASTHENIA 1187 0.0032
359 FEELING HOT 193 0.0031
360 SKIN MASS 21 0.0031
361 RECTAL HAEMORRHAGE 135 0.0031
362 PANCREATITIS 164 0.0031
363 LOCALISED INFECTION 74 0.0031
364 INJECTION SITE INFECTION 10 0.0030
365 ORAL PAIN 68 0.0030
366 HYPOKINESIA 44 0.0030
367 DIZZINESS 1510 0.0030
368 UNDERDOSE 218 0.0030
369 PRODUCT QUALITY ISSUE 401 0.0029
370 FEMORAL NECK FRACTURE 15 0.0029
371 DYSPNOEA 1650 0.0029
372 SKIN REACTION 41 0.0029
373 PAINFUL RESPIRATION 7 0.0029
374 ULCER 46 0.0029
375 OROPHARYNGEAL PAIN 266 0.0029
376 HAEMATOLOGICAL INFECTION 7 0.0029
377 OFF LABEL USE 2492 0.0028
378 BODY TEMPERATURE INCREASED 58 0.0028
379 INTENTIONAL DOSE OMISSION 81 0.0028
380 TONGUE DISCOMFORT 12 0.0028
381 PRODUCT DOSE OMISSION 184 0.0028
382 RESPIRATORY SYMPTOM 8 0.0028
383 DIARRHOEA 1805 0.0028
384 LIP PAIN 8 0.0028
385 ABDOMINAL PAIN 647 0.0028
386 BACTERAEMIA 33 0.0028
387 BLOOD TEST ABNORMAL 38 0.0027
388 INJECTION SITE INDURATION 35 0.0027
389 SYMPTOM RECURRENCE 16 0.0027
390 GASTROINTESTINAL PERFORATION 11 0.0026
391 HERPES ZOSTER 152 0.0026
392 PSORIASIS 345 0.0026
393 ARTHRITIS INFECTIVE 12 0.0026
394 ERYSIPELAS 13 0.0026
395 MULTIPLE-DRUG RESISTANCE 8 0.0026
396 LIP BLISTER 7 0.0026
397 NAUSEA 2033 0.0026
398 ORAL HERPES 50 0.0026
399 ORAL INFECTION 10 0.0026
400 ASPIRATION 28 0.0026
401 STAPHYLOCOCCAL BACTERAEMIA 11 0.0025
402 FURUNCLE 20 0.0025
403 LIMB DISCOMFORT 78 0.0025
404 COVID-19 440 0.0025
405 SUBCUTANEOUS ABSCESS 12 0.0025
406 TENDERNESS 26 0.0025
407 PHARYNGITIS STREPTOCOCCAL 27 0.0025
408 FUNGAL SKIN INFECTION 10 0.0025
409 ARTHRITIS BACTERIAL 10 0.0024
410 INITIAL INSOMNIA 25 0.0024
411 FIBULA FRACTURE 7 0.0024
412 ARTHROPOD BITE 18 0.0024
413 CELLULITIS 122 0.0024
414 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 432 0.0024
415 SCRATCH 25 0.0024
416 THORACIC VERTEBRAL FRACTURE 7 0.0024
417 GENERAL PHYSICAL CONDITION ABNORMAL 16 0.0024
418 INCORRECT PRODUCT ADMINISTRATION DURATION 51 0.0024
419 URINARY TRACT INFECTION 401 0.0023
420 RESPIRATORY TRACT INFECTION 61 0.0023
421 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
422 EYE INFECTION 26 0.0023
423 ORAL CANDIDIASIS 30 0.0023
424 FIBROSIS 7 0.0023
425 FULL BLOOD COUNT ABNORMAL 24 0.0023
426 ANXIETY 644 0.0023
427 NASAL DISORDER 6 0.0023
428 GASTROINTESTINAL ULCER 5 0.0023
429 STAPHYLOCOCCAL INFECTION 74 0.0022
430 WEIGHT DECREASED 626 0.0022
431 BLOOD BLISTER 7 0.0022
432 SKIN INFECTION 25 0.0022
433 EAR CONGESTION 6 0.0022
434 PRODUCT DOSE OMISSION ISSUE 651 0.0022
435 CARDIAC OPERATION 19 0.0022
436 RESPIRATORY TRACT CONGESTION 35 0.0022
437 LOSS OF THERAPEUTIC RESPONSE 7 0.0022
438 PLEURISY 13 0.0022
439 HEPATOCELLULAR INJURY 31 0.0022
440 NEUTROPHIL COUNT DECREASED 89 0.0022
441 ROTATOR CUFF SYNDROME 28 0.0022
442 KLEBSIELLA INFECTION 11 0.0022
443 PLEURITIC PAIN 6 0.0022
444 THERAPEUTIC RESPONSE DELAYED 6 0.0021
445 DECREASED IMMUNE RESPONSIVENESS 21 0.0021
446 FUNGAL INFECTION 71 0.0021
447 SINUS DISORDER 42 0.0021
448 NECK MASS 6 0.0021
449 ABSCESS LIMB 9 0.0021
450 PURULENT DISCHARGE 9 0.0021
451 INJECTION SITE DISCOMFORT 22 0.0021
452 CHAPPED LIPS 9 0.0021
453 CARPAL TUNNEL SYNDROME 29 0.0021
454 TREATMENT NONCOMPLIANCE 113 0.0021
455 BREATH ODOUR 5 0.0020
456 SKIN ULCER 53 0.0020
457 VULVOVAGINAL MYCOTIC INFECTION 8 0.0020
458 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
459 HYPERPHAGIA 8 0.0020
460 VEIN DISORDER 10 0.0020
461 VITAMIN D DECREASED 17 0.0020
462 TRANSAMINASES INCREASED 44 0.0020
463 DERMATITIS ACNEIFORM 12 0.0020
464 ENDODONTIC PROCEDURE 5 0.0020
465 LIMB INJURY 53 0.0019
466 DECREASED ACTIVITY 21 0.0019
467 UVEITIS 26 0.0019
468 SKIN ATROPHY 11 0.0019
469 INJECTION SITE PAIN 584 0.0019
470 INFLUENZA 212 0.0019
471 MOVEMENT DISORDER 61 0.0019
472 CARDIAC TAMPONADE 9 0.0019
473 PRODUCT PRESCRIBING ISSUE 41 0.0019
474 SNEEZING 42 0.0019
475 COMPRESSION FRACTURE 10 0.0019
476 HORDEOLUM 8 0.0018
477 HIP SURGERY 10 0.0018
478 POST PROCEDURAL INFECTION 15 0.0018
479 SECRETION DISCHARGE 23 0.0018
480 IMMOBILE 8 0.0018
481 THYROID MASS 7 0.0018
482 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
483 SUSPECTED COVID-19 6 0.0018
484 CHOLECYSTITIS INFECTIVE 5 0.0018
485 TACHYCARDIA 160 0.0018
486 UNEVALUABLE EVENT 136 0.0018
487 HOSPITALISATION 276 0.0018
488 NODULE 23 0.0018
489 SENSITIVE SKIN 13 0.0018
490 FOETAL EXPOSURE DURING PREGNANCY 143 0.0018
491 EXPOSURE VIA BREAST MILK 7 0.0018
492 PRODUCT TEMPERATURE EXCURSION ISSUE 9 0.0017
493 LUMBAR VERTEBRAL FRACTURE 8 0.0017
494 RASH MACULAR 61 0.0017
495 RASH ERYTHEMATOUS 83 0.0017
496 BILIARY COLIC 5 0.0017
497 SENSITIVITY TO WEATHER CHANGE 9 0.0017
498 DECREASED INTEREST 10 0.0017
499 ABSCESS 27 0.0017
500 HAEMORRHAGE SUBCUTANEOUS 6 0.0017
501 TOOTH EXTRACTION 21 0.0017
502 FULL BLOOD COUNT DECREASED 34 0.0017
503 FEAR OF INJECTION 12 0.0017
504 KIDNEY INFECTION 33 0.0017
505 INTERSTITIAL LUNG DISEASE 80 0.0017
506 CHEST X-RAY ABNORMAL 5 0.0016
507 MUSCULOSKELETAL DISORDER 31 0.0016
508 PIGMENTATION DISORDER 10 0.0016
509 HEPATOTOXICITY 36 0.0016
510 FRUSTRATION TOLERANCE DECREASED 13 0.0016
511 DIVERTICULUM INTESTINAL 7 0.0016
512 THROAT CLEARING 6 0.0016
513 RESPIRATION ABNORMAL 11 0.0016
514 DECUBITUS ULCER 13 0.0016
515 BRAIN FOG 25 0.0016
516 LEUKAEMIA 15 0.0016
517 BLOOD TRIGLYCERIDES INCREASED 28 0.0016
518 BLADDER PAIN 5 0.0016
519 ANAPHYLACTIC REACTION 87 0.0016
520 PARANASAL SINUS HYPERSECRETION 6 0.0016
521 MOUTH SWELLING 9 0.0016
522 FALL 517 0.0016
523 OROPHARYNGEAL DISCOMFORT 14 0.0015
524 INJECTION SITE NODULE 17 0.0015
525 PHARYNGITIS 19 0.0015
526 INCREASED TENDENCY TO BRUISE 14 0.0015
527 EYE OPERATION 7 0.0015
528 UROSEPSIS 14 0.0015
529 LIGAMENT SPRAIN 15 0.0015
530 NERVE COMPRESSION 14 0.0015
531 PNEUMOTHORAX 24 0.0015
532 RENAL CYST 12 0.0015
533 BACK PAIN 351 0.0015
534 MUSCLE STRAIN 13 0.0015
535 ROSACEA 7 0.0015
536 TIBIA FRACTURE 7 0.0015
537 GINGIVITIS 8 0.0015
538 CHEILITIS 8 0.0015
539 SPINAL DISORDER 14 0.0015
540 SKIN LACERATION 16 0.0015
541 MENISCUS INJURY 9 0.0015
542 CYST 18 0.0014
543 LARGE INTESTINE PERFORATION 10 0.0014
544 RASH PAPULAR 32 0.0014
545 QUALITY OF LIFE DECREASED 19 0.0014
546 FACIAL PARALYSIS 12 0.0014
547 GINGIVAL BLEEDING 19 0.0014
548 GASTROENTERITIS VIRAL 25 0.0014
549 MYELODYSPLASTIC SYNDROME 20 0.0014
550 CYSTITIS 44 0.0014
551 BLOOD DISORDER 11 0.0014
552 TONGUE DISCOLOURATION 6 0.0014
553 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 75 0.0014
554 CORONAVIRUS INFECTION 9 0.0014
555 PHYSICAL DISABILITY 6 0.0014
556 VARICOSE VEIN 7 0.0014
557 BLOOD IRON DECREASED 16 0.0013
558 SINUS HEADACHE 8 0.0013
559 POSTOPERATIVE WOUND INFECTION 9 0.0013
560 SINUS CONGESTION 18 0.0013
561 FACE INJURY 5 0.0013
562 SCAB 15 0.0013
563 ECCHYMOSIS 9 0.0013
564 RIB FRACTURE 27 0.0013
565 SKIN IRRITATION 60 0.0013
566 INJECTION SITE DISCHARGE 7 0.0013
567 HEAD DISCOMFORT 23 0.0013
568 TENDON RUPTURE 16 0.0013
569 LYMPHOMA 20 0.0013
570 SKIN HAEMORRHAGE 19 0.0013
571 NASAL DRYNESS 8 0.0013
572 HAND FRACTURE 9 0.0013
573 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
574 IMMUNOSUPPRESSION 11 0.0012
575 ENTEROCOCCAL INFECTION 6 0.0012
576 SEPTIC SHOCK 54 0.0012
577 SKIN DISCOLOURATION 57 0.0012
578 PERIORBITAL SWELLING 7 0.0012
579 BACTERIAL INFECTION 23 0.0012
580 VIRAL INFECTION 41 0.0012
581 COUGH 342 0.0012
582 PSYCHIATRIC SYMPTOM 9 0.0012
583 ORGANISING PNEUMONIA 6 0.0012
584 AORTIC DISSECTION 5 0.0012
585 BURNING SENSATION 84 0.0012
586 ERYTHEMA 246 0.0012
587 INTENTIONAL PRODUCT MISUSE 104 0.0012
588 HEPATIC STEATOSIS 22 0.0012
589 INJURY ASSOCIATED WITH DEVICE 24 0.0012
590 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
591 GASTRIC DISORDER 40 0.0012
592 ACCIDENTAL EXPOSURE TO PRODUCT 119 0.0012
593 THERAPY PARTIAL RESPONDER 18 0.0012
594 PRODUCT STORAGE ERROR 101 0.0012
595 APHONIA 16 0.0011
596 NEUTROPENIA 155 0.0011
597 GROIN PAIN 10 0.0011
598 SPINAL OSTEOARTHRITIS 10 0.0011
599 NEEDLE ISSUE 33 0.0011
600 VITAMIN D DEFICIENCY 11 0.0011
601 PHARYNGEAL SWELLING 11 0.0011
602 FACIAL PAIN 10 0.0011
603 SWELLING OF EYELID 7 0.0011
604 NEPHROLITHIASIS 51 0.0011
605 NEURALGIA 27 0.0011
606 SPINAL PAIN 13 0.0011
607 ANKLE FRACTURE 17 0.0011
608 HEPATIC CYTOLYSIS 14 0.0011
609 TENDONITIS 17 0.0011
610 MOUTH HAEMORRHAGE 8 0.0011
611 THROMBOCYTOPENIA 122 0.0011
612 PRODUCTIVE COUGH 52 0.0011
613 BREAST CANCER STAGE I 10 0.0011
614 PULMONARY MASS 16 0.0011
615 PLATELET COUNT INCREASED 14 0.0011
616 SUNBURN 8 0.0011
617 ANKYLOSING SPONDYLITIS 14 0.0011
618 SEASONAL ALLERGY 15 0.0011
619 CHOLECYSTITIS ACUTE 6 0.0011
620 ALANINE AMINOTRANSFERASE INCREASED 65 0.0011
621 TENDON PAIN 8 0.0011
622 GENERALISED OEDEMA 13 0.0010
623 OSTEOMYELITIS 19 0.0010
624 RENAL PAIN 11 0.0010
625 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
626 VASCULITIS 12 0.0010
627 MYALGIA 173 0.0010
628 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
629 HYPERSOMNIA 29 0.0010
630 NASAL DISCOMFORT 8 0.0010
631 PRODUCT PRESCRIBING ERROR 24 0.0010
632 SKIN EXFOLIATION 85 0.0010
633 HIATUS HERNIA 13 0.0010
634 DEPRESSED MOOD 53 0.0010
635 SPINAL FRACTURE 20 0.0010
636 BLOOD POTASSIUM DECREASED 30 0.0010
637 BEDRIDDEN 13 0.0010
638 LYMPHADENOPATHY 35 0.0010
639 MUSCLE DISORDER 8 0.0010
640 THERMAL BURN 7 0.0010
641 INGUINAL HERNIA 6 0.0010
642 EATING DISORDER 21 0.0010
643 JOINT INJURY 21 0.0010
644 SWELLING FACE 64 0.0010
645 PARALYSIS 14 0.0010
646 HYPOKALAEMIA 45 0.0010
647 ENDOCARDITIS 5 0.0010
648 INFLUENZA LIKE ILLNESS 80 0.0010
649 FEELING COLD 27 0.0010
650 SPINAL COMPRESSION FRACTURE 8 0.0010
651 MICTURITION URGENCY 11 0.0010
652 CHOLECYSTECTOMY 11 0.0010
653 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
654 FLANK PAIN 9 0.0010
655 ORAL DISORDER 7 0.0010
656 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
657 CANDIDA INFECTION 16 0.0009
658 TOOTHACHE 17 0.0009
659 BONE PAIN 55 0.0009
660 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
661 PAROSMIA 7 0.0009
662 HYSTERECTOMY 8 0.0009
663 PYELONEPHRITIS 8 0.0009
664 DRY SKIN 123 0.0009
665 HAEMODYNAMIC INSTABILITY 7 0.0009
666 PULMONARY THROMBOSIS 10 0.0009
667 ATRIOVENTRICULAR BLOCK 7 0.0009
668 BLOOD PRESSURE ABNORMAL 18 0.0009
669 MUSCULOSKELETAL CHEST PAIN 14 0.0009
670 CHILLS 106 0.0009
671 ACCIDENTAL OVERDOSE 33 0.0009
672 RESPIRATORY RATE INCREASED 8 0.0009
673 LIP SWELLING 30 0.0009
674 FOOT FRACTURE 17 0.0009
675 INJECTION SITE EXTRAVASATION 11 0.0009
676 DYSSTASIA 26 0.0009
677 DRY THROAT 9 0.0009
678 HEART RATE IRREGULAR 20 0.0009
679 NEOPLASM MALIGNANT 59 0.0009
680 DRY EYE 44 0.0009
681 DERMATITIS CONTACT 10 0.0009
682 DERMATITIS ALLERGIC 11 0.0009
683 CATARACT 52 0.0009
684 ONYCHOCLASIS 6 0.0009
685 RHINITIS 7 0.0009
686 LYMPHOEDEMA 6 0.0009
687 ENTEROCOLITIS 5 0.0009
688 PLATELET COUNT DECREASED 92 0.0009
689 AGRANULOCYTOSIS 16 0.0009
690 POOR QUALITY PRODUCT ADMINISTERED 9 0.0009
691 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
692 NEUROPATHY PERIPHERAL 81 0.0009
693 ESCHERICHIA INFECTION 7 0.0009
694 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
695 IMPAIRED WORK ABILITY 18 0.0008
696 GASTRIC ULCER 16 0.0008
697 SKIN DISORDER 28 0.0008
698 BREAST CANCER 78 0.0008
699 VERTIGO 51 0.0008
700 WRIST FRACTURE 10 0.0008
701 PARAESTHESIA ORAL 12 0.0008
702 ASPARTATE AMINOTRANSFERASE INCREASED 44 0.0008
703 DIZZINESS POSTURAL 8 0.0008
704 HAEMORRHOIDS 16 0.0008
705 PAIN OF SKIN 22 0.0008
706 CYTOPENIA 10 0.0008
707 HAEMATOCHEZIA 45 0.0008
708 HEPATOMEGALY 8 0.0008
709 PANCYTOPENIA 45 0.0008
710 RED BLOOD CELL COUNT DECREASED 23 0.0008
711 INTESTINAL PERFORATION 9 0.0008
712 OCULAR DISCOMFORT 9 0.0008
713 RENAL DISORDER 37 0.0008
714 POLLAKIURIA 33 0.0008
715 LIVER FUNCTION TEST ABNORMAL 23 0.0008
716 MUSCLE ATROPHY 10 0.0008
717 INTERNAL HAEMORRHAGE 9 0.0008
718 MASS 11 0.0008
719 TOOTH ABSCESS 8 0.0008
720 SLUGGISHNESS 8 0.0008
721 FAECES DISCOLOURED 17 0.0008
722 THROMBOSIS 63 0.0008
723 THROAT IRRITATION 35 0.0008
724 EAR DISCOMFORT 8 0.0008
725 PRODUCT PREPARATION ERROR 16 0.0008
726 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
727 PAIN IN JAW 22 0.0008
728 LACRIMATION INCREASED 23 0.0008
729 MENTAL DISORDER 33 0.0008
730 BLOOD GLUCOSE ABNORMAL 14 0.0008
731 APPETITE DISORDER 5 0.0008
732 GINGIVAL PAIN 6 0.0008
733 ACCIDENT 9 0.0008
734 ABDOMINAL PAIN LOWER 19 0.0008
735 NO ADVERSE EVENT 136 0.0007
736 BREAST MASS 5 0.0007
737 STENT PLACEMENT 6 0.0007
738 MUSCLE TIGHTNESS 12 0.0007
739 FRACTURE 14 0.0007
740 FEEDING DISORDER 15 0.0007
741 SPUTUM DISCOLOURED 7 0.0007
742 EYE INFLAMMATION 7 0.0007
743 CHOLESTASIS 14 0.0007
744 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 38 0.0007
745 GASTROINTESTINAL PAIN 8 0.0007
746 MELAENA 16 0.0007
747 EYE SWELLING 27 0.0007
748 BLOOD COUNT ABNORMAL 11 0.0007
749 GOUT 13 0.0007
750 TINNITUS 33 0.0007
751 DYSPHONIA 42 0.0007
752 FEELING ABNORMAL 172 0.0007
753 FEMUR FRACTURE 22 0.0007
754 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13 0.0007
755 LYMPHOPENIA 10 0.0007
756 BLADDER DISORDER 7 0.0007
757 SWOLLEN TONGUE 22 0.0007
758 PSEUDOMONAS INFECTION 6 0.0007
759 BLOOD MAGNESIUM DECREASED 6 0.0007
760 PERICARDIAL EFFUSION 16 0.0007
761 DERMATITIS BULLOUS 5 0.0007
762 GASTROENTERITIS 10 0.0007
763 GASTRITIS 18 0.0007
764 METASTASES TO LIVER 12 0.0007
765 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
766 LUNG NEOPLASM MALIGNANT 28 0.0007
767 PURPURA 6 0.0007
768 CEREBRAL DISORDER 5 0.0007
769 HEAVY MENSTRUAL BLEEDING 6 0.0007
770 INJECTION SITE HAEMORRHAGE 53 0.0007
771 DRUG EFFECT INCOMPLETE 24 0.0007
772 ACNE 50 0.0007
773 UPPER LIMB FRACTURE 13 0.0007
774 DYSURIA 24 0.0007
775 HYPOACUSIS 28 0.0006
776 SKIN CANCER 14 0.0006
777 IRON DEFICIENCY ANAEMIA 6 0.0006
778 PROCEDURAL PAIN 18 0.0006
779 FOOD ALLERGY 5 0.0006
780 HYPERHIDROSIS 83 0.0006
781 SKIN BURNING SENSATION 46 0.0006
782 OVERDOSE 138 0.0006
783 EYE DISORDER 21 0.0006
784 DENTAL CARIES 7 0.0006
785 DISTURBANCE IN ATTENTION 34 0.0006
786 TOOTH DISORDER 14 0.0006
787 SLEEP APNOEA SYNDROME 12 0.0006
788 ATRIAL FLUTTER 5 0.0006
789 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
790 HIP FRACTURE 20 0.0006
791 SKIN LESION 17 0.0006
792 CEREBRAL INFARCTION 15 0.0006
793 ARRHYTHMIA 29 0.0006
794 COLITIS 23 0.0006
795 PHOTOSENSITIVITY REACTION 10 0.0006
796 PELVIC PAIN 11 0.0006
797 THERAPY CESSATION 31 0.0006
798 HYPOTONIA 6 0.0006
799 HYPOAESTHESIA ORAL 9 0.0006
800 OSTEOPENIA 9 0.0006
801 VAGINAL DISCHARGE 6 0.0006
802 SEPSIS 66 0.0006
803 MOOD ALTERED 16 0.0006
804 DEVICE RELATED INFECTION 9 0.0006
805 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
806 CARDIAC DISORDER 54 0.0006
807 PETECHIAE 6 0.0006
808 ACUTE RESPIRATORY FAILURE 11 0.0006
809 GLAUCOMA 11 0.0006
810 LOSS OF CONSCIOUSNESS 73 0.0006
811 BLOOD PRESSURE INCREASED 87 0.0006
812 EPISTAXIS 42 0.0006
813 GASTROINTESTINAL INFECTION 5 0.0006
814 HOT FLUSH 42 0.0006
815 PRURITUS GENERALISED 12 0.0006
816 PRODUCT DISPENSING ERROR 12 0.0006
817 DIPLOPIA 14 0.0005
818 CONJUNCTIVITIS 10 0.0005
819 INCORRECT DOSE ADMINISTERED 123 0.0005
820 DRUG EFFECT DECREASED 29 0.0005
821 ECZEMA 28 0.0005
822 PULMONARY CONGESTION 7 0.0005
823 IMPAIRED DRIVING ABILITY 6 0.0005
824 BLOOD URINE PRESENT 10 0.0005
825 MALIGNANT MELANOMA 7 0.0005
826 THYROID DISORDER 8 0.0005
827 HERNIA 10 0.0005
828 HAEMORRHAGE 54 0.0005
829 SKIN FISSURES 10 0.0005
830 DIABETES MELLITUS 39 0.0005
831 BALANCE DISORDER 44 0.0005
832 DRUG ERUPTION 9 0.0005
833 EYE PRURITUS 17 0.0005
834 MENTAL STATUS CHANGES 14 0.0005
835 RASH GENERALISED 13 0.0005
836 BLOOD PRESSURE DECREASED 33 0.0005
837 ANGINA PECTORIS 14 0.0005
838 OCULAR HYPERAEMIA 23 0.0005
839 MIDDLE INSOMNIA 9 0.0005
840 EYE DISCHARGE 5 0.0005
841 BLOOD SODIUM DECREASED 9 0.0005
842 DEEP VEIN THROMBOSIS 31 0.0005
843 PLEURAL EFFUSION 29 0.0005
844 COLON CANCER 7 0.0005
845 SCAR 8 0.0005
846 CHEST DISCOMFORT 47 0.0005
847 DEAFNESS 12 0.0005
848 BLOOD PRESSURE FLUCTUATION 11 0.0005
849 INSURANCE ISSUE 7 0.0005
850 ANAEMIA 86 0.0005
851 EYE PAIN 25 0.0004
852 NERVOUSNESS 23 0.0004
853 BONE DISORDER 8 0.0004
854 PERIPHERAL COLDNESS 6 0.0004
855 CONSTIPATION 95 0.0004
856 PERITONITIS 9 0.0004
857 CARDIOVASCULAR DISORDER 11 0.0004
858 CAESAREAN SECTION 5 0.0004
859 THINKING ABNORMAL 8 0.0004
860 HEPATIC FUNCTION ABNORMAL 16 0.0004
861 OXYGEN SATURATION DECREASED 24 0.0004
862 PALPITATIONS 50 0.0004
863 DEVICE MALFUNCTION 30 0.0004
864 OSTEONECROSIS 14 0.0004
865 PULMONARY OEDEMA 19 0.0004
866 FLATULENCE 24 0.0004
867 DYSPHAGIA 40 0.0004
868 POST PROCEDURAL COMPLICATION 8 0.0004
869 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
870 ANOSMIA 6 0.0004
871 BREAST CANCER FEMALE 11 0.0004
872 ATRIAL FIBRILLATION 40 0.0004
873 ABNORMAL WEIGHT GAIN 5 0.0004
874 HEART RATE INCREASED 40 0.0004
875 PANCREATITIS ACUTE 9 0.0004
876 DYSPNOEA EXERTIONAL 15 0.0004
877 RESPIRATORY FAILURE 29 0.0004
878 HYPOXIA 14 0.0004
879 HAEMOPTYSIS 11 0.0004
880 BONE MARROW FAILURE 8 0.0004
881 GALLBLADDER DISORDER 7 0.0004
882 SHOCK 9 0.0004
883 HYPOTENSION 78 0.0004
884 HAEMATURIA 13 0.0004
885 THERAPY INTERRUPTED 27 0.0004
886 SENSORY DISTURBANCE 6 0.0004
887 POOR QUALITY SLEEP 8 0.0004
888 URINARY INCONTINENCE 11 0.0004
889 THROAT TIGHTNESS 10 0.0004
890 PULMONARY EMBOLISM 35 0.0004
891 PROTEINURIA 7 0.0004
892 PNEUMONITIS 10 0.0004
893 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
894 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 17 0.0004
895 AGEUSIA 9 0.0004
896 PNEUMONIA ASPIRATION 9 0.0004
897 TREMOR 59 0.0004
898 CHROMATURIA 8 0.0004
899 BLOOD GLUCOSE DECREASED 17 0.0004
900 CEREBROVASCULAR ACCIDENT 59 0.0003
901 HAEMATOMA 9 0.0003
902 DEVICE DEFECTIVE 6 0.0003
903 BLOOD GLUCOSE INCREASED 65 0.0003
904 COLD SWEAT 6 0.0003
905 BLOOD BILIRUBIN INCREASED 9 0.0003
906 HEPATIC FAILURE 10 0.0003
907 EXPIRED PRODUCT ADMINISTERED 11 0.0003
908 CRYING 12 0.0003
909 RESTLESSNESS 12 0.0003
910 SOMNOLENCE 66 0.0003
911 VISION BLURRED 44 0.0003
912 NERVOUS SYSTEM DISORDER 10 0.0003
913 INCREASED APPETITE 6 0.0003
914 CARDIAC FAILURE 25 0.0003
915 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
916 CHOKING 6 0.0003
917 ASCITES 9 0.0003
918 CHOLELITHIASIS 10 0.0003
919 DEHYDRATION 40 0.0003
920 RESPIRATORY DISTRESS 8 0.0003
921 RENAL IMPAIRMENT 24 0.0003
922 EOSINOPHILIA 5 0.0003
923 HEART RATE DECREASED 10 0.0003
924 CARDIAC ARREST 23 0.0003
925 PANCREATIC CARCINOMA 8 0.0003
926 HAEMOGLOBIN DECREASED 28 0.0003
927 BLINDNESS 11 0.0003
928 DEATH 229 0.0003
929 APHASIA 8 0.0003
930 MYOCARDIAL INFARCTION 46 0.0003
931 LETHARGY 15 0.0003
932 EMOTIONAL DISORDER 8 0.0003
933 ERUCTATION 5 0.0003
934 DYSGEUSIA 19 0.0003
935 ACUTE KIDNEY INJURY 39 0.0003
936 MOOD SWINGS 8 0.0003
937 MYELOSUPPRESSION 9 0.0002
938 SPEECH DISORDER 13 0.0002
939 HYPERGLYCAEMIA 9 0.0002
940 PRESYNCOPE 6 0.0002
941 ENCEPHALOPATHY 6 0.0002
942 DERMATITIS 5 0.0002
943 HYPOPHAGIA 6 0.0002
944 SEIZURE 27 0.0002
945 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
946 FLUSHING 23 0.0002
947 ABORTION SPONTANEOUS 9 0.0002
948 CARDIAC FAILURE CONGESTIVE 18 0.0002
949 CEREBRAL HAEMORRHAGE 8 0.0002
950 DYSKINESIA 9 0.0002
951 DRUG INTERACTION 35 0.0002
952 RENAL FAILURE 29 0.0002
953 CARDIO-RESPIRATORY ARREST 9 0.0002
954 INTESTINAL OBSTRUCTION 8 0.0002
955 DISEASE RECURRENCE 10 0.0002
956 BRADYCARDIA 11 0.0002
957 ANGER 7 0.0002
958 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
959 NIGHTMARE 7 0.0002
960 HALLUCINATION 15 0.0002
961 ERECTILE DYSFUNCTION 5 0.0002
962 DRUG RESISTANCE 5 0.0002
963 HEAD INJURY 6 0.0002
964 HYPOTHYROIDISM 6 0.0002
965 SYNCOPE 18 0.0002
966 URINARY RETENTION 6 0.0002
967 CHRONIC KIDNEY DISEASE 13 0.0002
968 HYPERKALAEMIA 6 0.0002
969 ACUTE MYOCARDIAL INFARCTION 5 0.0002
970 BONE DENSITY DECREASED 5 0.0002
971 IRRITABILITY 9 0.0001
972 PROSTATE CANCER 12 0.0001
973 DRUG DOSE OMISSION 24 0.0001
974 DEVICE ISSUE 13 0.0001
975 DISEASE PROGRESSION 16 0.0001
976 DERMATITIS ATOPIC 7 0.0001
977 EXTRA DOSE ADMINISTERED 5 0.0001
978 EYE IRRITATION 7 0.0001
979 ANGIOEDEMA 5 0.0001
980 COGNITIVE DISORDER 5 0.0001
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
982 BLOOD CREATININE INCREASED 6 0.0001
983 DEVICE DIFFICULT TO USE 6 0.0001
984 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
985 SUICIDAL IDEATION 8 0.0001
986 FEBRILE NEUTROPENIA 5 0.0001
987 DRUG DEPENDENCE 8 0.0000
988 TOXICITY TO VARIOUS AGENTS 8 0.0000